HTG Molecular Diagnostics to Announce Year End 2020 Financial Results and Host Conference Call on Thursday, March 25
HTG Molecular Diagnostics (Nasdaq: HTGM) announced it will report financial results for the year ending December 31, 2020, after market close on March 25, 2021. The company will also host a conference call at 4:30 PM Eastern Time to discuss these results and provide a corporate update. HTG specializes in NGS-based molecular profiling, utilizing its proprietary HTG EdgeSeq technology to automate complex molecular profiling from various sample types, aiding in precision medicine.
- None.
- None.
TUCSON, Ariz., March 16, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report its financial results for the year ended December 31, 2020 after the market close on Thursday, March 25, 2021. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time.
Conference Call & Webcast Details | |
Date: | Thursday, March 25 |
Time: | 4:30 pm Eastern Time |
Toll Free: | 877-407-0789 |
International: | 201-689-8562 |
Conference ID: | 13715845 |
Webcast: | http://public.viavid.com/index.php?id=143331 |
About HTG
HTG is focused on NGS-based molecular profiling. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. Its mission is to empower precision medicine.
Contact:
Ashley R. Robinson
LifeSci Advisors, LLC
Phone: (617) 430-7577
Email: arr@lifesciadvisors.com
FAQ
When will HTG Molecular Diagnostics release its financial results?
What time is the HTG Molecular Diagnostics conference call?
What is HTG Molecular Diagnostics' focus in the life sciences?